Published in Hum Pathol on September 01, 1999
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood (2014) 2.30
Erdheim-Chester Disease: a comprehensive review of the literature. Orphanet J Rare Dis (2013) 1.54
Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol (2006) 1.47
Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol (2006) 1.17
Systemic Erdheim-Chester disease. Virchows Arch (2008) 0.97
Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases. Adv Immunol (2013) 0.95
Oncogene-induced senescence as a new mechanism of disease: the paradigm of erdheim-chester disease. Front Immunol (2014) 0.95
An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis. Skeletal Radiol (2007) 0.90
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series. BMC Med (2014) 0.85
Erdheim-Chester disease of the breast associated with Langerhans-cell histiocytosis of the hard palate. Virchows Arch (2004) 0.81
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature. Rheumatol Int (2011) 0.79
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim Chester disease in adults. Blood (2017) 0.76
Role of (99m)Tc-MDP bone scan in the diagnosis of Erdheim-Chester disease. Indian J Nucl Med (2014) 0.75
Erdheim-chester disease associated with marginal zone lymphoma and monoclonal proteinemia. Case Rep Hematol (2011) 0.75
Erdheim-Chester disease (ECD): Case report, clinical and basic investigations, and review of literature. Medicine (Baltimore) (2016) 0.75
[Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis]. Pathologe (2015) 0.75
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet (1997) 10.05
Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) (1996) 4.52
High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology (2001) 2.41
A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study Group. AIDS (1997) 2.21
Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol (2001) 2.09
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med (1995) 2.06
Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis (2011) 2.05
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology (1995) 2.00
Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology (2000) 1.97
Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology (1999) 1.94
Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol (2001) 1.88
Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology (1997) 1.84
Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun (1991) 1.71
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry (2008) 1.71
A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology (1991) 1.70
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut (2005) 1.65
Appropriateness of liver biopsy. Can J Gastroenterol (2000) 1.65
Primary cutaneous pleomorphic small T-cell lymphoma. A review of 11 cases. The French Study Group on Cutaneous Lymphomas. Arch Dermatol (1995) 1.64
Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery. Gut (2008) 1.63
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol (1987) 1.62
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet (2001) 1.62
Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol (2000) 1.61
The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.61
Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood (2000) 1.59
Pachydermodactyly and atrophia maculosa varioliformis cutis. Dermatology (1995) 1.57
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. Gut (2009) 1.56
Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol (1999) 1.56
Pancreatic lesions in AIDS. Lancet (1987) 1.55
Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res (2000) 1.53
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Arch Dermatol (2001) 1.50
Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol (1999) 1.47
Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation (1997) 1.46
Morphologic structure of bile canaliculi after bile duct ligation in the rat. A time-course study. Arch Pathol Lab Med (1982) 1.45
Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol (1995) 1.43
[Melanoma of the penis: 6 cases]. Ann Dermatol Venereol (2004) 1.42
Hepatitis C virus infection with and without cryoglobulinemia as a case of Churg-Strauss syndrome. J Rheumatol (2000) 1.39
[Prognosis and prognostic factors in oncology and oncologic surgery ]. Vnitr Lek (2004) 1.38
[Epstein-Barr virus: pathologic implications]. Ann Pathol (1998) 1.38
The course of hepatitis C virus infection after liver transplantation. Hepatology (1994) 1.38
Neuropathology of early HIV-1 infection. Brain Pathol (1996) 1.37
Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease. Peptides (2007) 1.36
The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum (1993) 1.36
Is ketamine or its preservative responsible for neurotoxicity in the rabbit? Anesthesiology (1993) 1.33
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol (2007) 1.33
In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology (1997) 1.30
Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat (1997) 1.29
Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol (2001) 1.28
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 1.28
Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol (1996) 1.27
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood (2000) 1.27
Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin Diagn Lab Immunol (2000) 1.26
Alpha-2-macroglobulin and hepatic fibrosis. Diagnostic interest. Dig Dis Sci (1994) 1.26
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology (1996) 1.26
Ketamine and midazolam neurotoxicity in the rabbit. Anesthesiology (1991) 1.25
A homozygous insertion-deletion in the type VII collagen gene (COL7A1) in Hallopeau-Siemens dystrophic epidermolysis bullosa. Nat Genet (1993) 1.25
Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology (1997) 1.24
Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1. Br J Dermatol (2005) 1.23
Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy. AIDS (2000) 1.23
Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers. J Hepatol (1998) 1.23
Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol (1995) 1.22
Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol (1996) 1.21
Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol (2013) 1.20
In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol (1997) 1.20
Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol (1988) 1.19
Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice. Nature (1991) 1.18
The multicentre south European study 'Helios'. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.17
Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol (2001) 1.17
CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol (1997) 1.15
Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness. Br J Cancer (2009) 1.13
[Electron microscopic study of nerve, muscle and skin lesions induced by perhexiline maleate (author's transl)]. Acta Neuropathol (1977) 1.12
Stevens-Johnson syndrome induced by cyclophosphamide: report of two cases. Br J Dermatol (1996) 1.12
Occurrence of polyglucosan bodies in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (1992) 1.12
CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). Am J Surg Pathol (1999) 1.10
Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol (1995) 1.09
Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol (1999) 1.09
Subcutaneous tumoral seeding from a glioblastoma following stereotactic biopsy: case report and review of the literature. Clin Neuropathol (2005) 1.08
Gene expression and hepatitis C virus infection. Gut (2008) 1.08
Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol (1999) 1.08
Erdheim-Chester disease presenting as malignant exophthalmos. Br J Radiol (1986) 1.08
Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor. J Virol (1993) 1.08
Portal hypertensive colopathy. A new entity. Dig Dis Sci (1991) 1.08
Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res (1997) 1.07
Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. Gastroenterology (1996) 1.07
Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain. J Virol (1995) 1.06
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats. Exp Neurol (2007) 1.05
Biomechanical wall properties of human intracranial aneurysms resected following surgical clipping (IRRAs Project). J Biomech (2011) 1.05
Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002). Br J Cancer (2003) 1.05
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood (1998) 1.04
The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol (2011) 1.03
TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am J Physiol (1994) 1.03
Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. Blood (1995) 1.03